Laser based procedures are expected to register the fastest growth in the benign Prostatic Hyperplasia Treatment devices market during the forecast period, since these procedures are as effective as surgical procedures, reduce the hospital stay time and do not leave any scars post treatment. Benign prostatic hyperplasia refers to the enlargement of the prostate gland which obstructs the passage of urine through urethra in men. The disease is more common in aging men, and about half of all men between the age of 51 to 60 years suffer from the disease.
Growing aging population, rising prevalence of benign prostatic hyperplasia, rise in the awareness about various benign prostatic hyperplasia disorders and surge in the adoption of minimally invasive procedures are the some of the major factors driving the demand for benign prostatic hyperplasia treatment devices.
Reimbursement for benign prostatic hyperplasia procedures and growing healthcare market in emerging countries provides ample growth opportunities to the players operating in the benign prostatic hyperplasia treatment devices industry.
In March 2017, NeoTract Inc. announced the expansion of its minimally invasive procedure device, UroLift System, to be available in Ireland. The geographical expansion of the product in Ireland was supported by Vhi group, a private health insurance firm. In June 2017, Olympus Corporation announced the expansion of its PLASMA Resection in Africa that provides clinical benefits and cost saving procedure, in comparison to monopolar TURP.In September 2016, NeoTract, Inc. announced that the company has received the de novo approval from USFDA for its UroLift System for prostate implant.
News Courtesy: P&S Market Research
Tagged: Benign Prostatic Hyperplasia Treatment Devices, Benign Prostatic Hyperplasia Treatment Devices Industry, Benign Prostatic Hyperplasia Treatment Devices Market, BPH Treatment, BPH Treatment Devices Market, BPH Treatment Devices Market Analysis, BPH Treatment Devices Market Demand, BPH Treatment Devices Market Growth Factors, BPH Treatment Devices Market Size